Jeffrey Low Biography

Jeffrey Low is a deal partner at the a16z Bio Fund. He is an MD by training who combines his medical expertise with experiences from biotech to software to help entrepreneurs using technology to transform healthcare and biology. At a16z he has worked on investments in Accolade CAMP4 Therapeutics Ciitzen Devoted Health and InSitro. Prior to a16z his investments include Omada Health and Lemonaid Health. His current interests include AI in healthcare computational and engineering driven therapeutic platforms and scaling healthcare technology companies. Prior to joining a16z in 2016 Jeffrey worked with Google Capital (now CapitalG) on growth healthcare investments. Previously he worked on biotech and digital health investments at Novartis Venture Fund and dRx Capital. Jeffrey began his career working directly with the founders at St. Francis Medical Technologies (acquired by Kyphon/Medtronic) and subsequently held scientific and strategic roles at two medical technology startups. Jeffrey works closely with the boards of Apeel Sciences Asimov BioAge Labs Cardiogram Freenome Omada Health PatientPing and Rigetti Computing. Jeffrey received an MD from Yale School of Medicine an MBA Harvard Business School and an AB in Molecular and Cellular Biology from Harvard.

As a renowned expert and highly sought-after speaker, Jeffrey Low's expertise is in high demand. To book Jeffrey Low for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Jeffrey Low's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Jeffrey Low's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Jeffrey Low for your next speaking engagement.